BOSTON, January 06, 2026--1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

The chief medical officer is interested in an easier path to market for health screening features in wearable devices.

The collaboration leverages BostonGene's foundation model for tumor and immune biology to deliver predictive insights on patient-level safety and efficacy outcomes in early clinical trials.

We put each pair through heavy barbell sessions, CrossFit workouts, and hybrid training to find the shoes that actually ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat ...

Foreign investors should assess Singapore’s local director and management presence rules, nominee disclosure updates, and ...

Leila Turner-Scott reads a conversation her son Sam had with ChatGPT on the day of his death while at her home in Dripping ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

A heartbreaking incident in California has reignited global discussions about AI safety, youth vulnerability, and digital ...